|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nault JC, Calderaro J, Di Tommaso L,
Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M and Zucman-Rossi
J: Telomerase reverse transcriptase promoter mutation is an early
somatic genetic alteration in the transformation of premalignant
nodules in hepatocellular carcinoma on cirrhosis. Hepatology.
60:1983–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kerr SH and Kerr DJ: Novel treatments for
hepatocellular cancer. Cancer Lett. 286:114–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arslan C, Ozdemir E, Dogan E, Ozisik Y and
Altundag K: Secondary hematological malignancies after treatment of
non-metastatic breast cancer. J BUON. 16:744–750. 2011.
|
|
5
|
Roufayel R, Johnston DS and Mosser DD: The
elimination of miR-23a in heat-stressed cells promotes NOXA-induced
cell death and is prevented by HSP70. Cell Death Dis. 27:e15462014.
View Article : Google Scholar
|
|
6
|
Nair N and Gongora E: MicroRNAs as
therapeutic targets in cardiomyopathies: Myth or reality? Biomol
Concepts. 5:439–448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang H, Cheng Y, Jia C, Yu S, Xiao Y and
Chen J: MicroRNA-29s could target AKT2 to inhibit gastric cancer
cells invasion ability. Med Oncol. 32:3422015. View Article : Google Scholar
|
|
8
|
Zhang L, Ge Y and Fuchs E: miR-125b can
enhance skin tumor initiation and promote malignant progression by
repressing differentiation and prolonging cell survival. Genes Dev.
28:2532–2546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S and Li K: MicroRNA-96 regulates
RGC-5 cell growth through caspase-dependent apoptosis. Int J Clin
Exp Med. 7:3694–3702. 2014.PubMed/NCBI
|
|
10
|
Wolfson B, Eades G and Zhou Q: Roles of
microRNA-140 in stem cell-associated early stage breast cancer.
World J Stem Cells. 6:591–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mo ZH, Wu XD, Li S, Fei BY and Zhang B:
Expression and clinical significance of microRNA-376a in colorectal
cancer. Asian Pac J Cancer Prev. 15:9523–9527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Woo SM, Min KJ, Seo BR, Nam JO, Choi KS,
Yoo YH and Kwon TK: Cafestol overcomes ABT-737 resistance in
Mcl-1-overexpressed renal carcinoma Caki cells through
downregulation of Mcl-1 expression and upregulation of Bim
expression. Cell Death Dis. 5:e15142014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Amaral C, Borges M, Melo S, da Silva ET,
Correia-da-Silva G and Teixeira N: Apoptosis and autophagy in
breast cancer cells following exemestane treatment. PLoS One.
7:e423982012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mu YP, Tang S, Sun WJ, Gao WM, Wang M and
Su XL: Association of miR-193b down-regulation and miR-196a
up-regulation with clinicopathological features and prognosis in
gastric cancer. Asian Pac J Cancer Prev. 15:8893–8900. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014.PubMed/NCBI
|
|
18
|
Liu R, Liu X, Zheng Y, Gu J, Xiong S,
Jiang P, Jiang X, Huang E, Yang Y, Ge D, et al: MicroRNA-7
sensitizes non-small cell lung cancer cells to paclitaxel. Oncol
Lett. 8:2193–2200. 2014.PubMed/NCBI
|
|
19
|
Boyerinas B, Park SM, Murmann AE, Gwin K,
Montag AG, Zillhardt M, Hua YJ, Lengyel E and Peter ME: Let-7
modulates acquired resistance of ovarian cancer to Taxanes via
IMP-1-mediated stabilization of multidrug resistance 1. Int J
Cancer. 130:1787–1797. 2012. View Article : Google Scholar
|
|
20
|
Koga C, Kobayashi S, Nagano H, Tomimaru Y,
Hama N, Wada H, Kawamoto K, Eguchi H, Konno M, Ishii H, et al:
Reprogramming using microRNA-302 improves drug sensitivity in
hepatocellular carcinoma cells. Ann Surg Oncol. 21(Suppl 4):
S591–S600. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Creagh EM: Caspase crosstalk: integration
of apoptotic and innate immune signalling pathways. Trends Immunol.
35:631–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Childs BG, Baker DJ, Kirkland JL, Campisi
J and van Deursen JM: Senescence and apoptosis: Dueling or
complementary cell fates? EMBO Rep. 15:1139–1153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Setia S, Nehru B and Sanyal SN: Celecoxib
prevents colitis associated colon carcinogenesis: An upregulation
of apoptosis. Pharmacol Rep. 66:1083–1091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang P, Tuo L, Wu Q and Cao X:
Licochalcone-A sensitizes human esophageal carcinoma cells to
TRAIL-mediated apoptosis by proteasomal degradation of XIAP.
Hepatogastroenterology. 61:1229–1234. 2014.PubMed/NCBI
|
|
25
|
Lee HG, Lee JM, Shin SJ, Kwon SH, Lee GS,
Song CH, Choi ES, Cha SD and Cho CH: Salinomycin inhibited cell
proliferation and induced apoptosis in human uterine leiomyoma
cells. Obstet Gynecol Sci. 57:501–506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao J, Li X, Zou M, He J, Han Y, Wu D,
Yang H and Wu J: miR-135a inhibition protects A549 cells from
LPS-induced apoptosis by targeting Bcl-2. Biochem Biophys Res
Commun. 452:951–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rao YM, Shi HR, Ji M and Chen CH: miR-106a
targets Mcl-1 to suppress cisplatin resistance of ovarian cancer
A2780 cells. J Huazhong Univ Sci Technolog Med Sci. 33:567–572.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang R, Li Y, Dong X, Peng L and Nie X:
miR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1
in breast cancer. Med Oncol. 31:3472014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Geserick P, Wang J, Feoktistova M and
Leverkus M: The ratio of Mcl-1 and Noxa determines ABT737
resistance in squamous cell carcinoma of the skin. Cell Death Dis.
5:e14122014. View Article : Google Scholar : PubMed/NCBI
|
